<DOC>
	<DOCNO>NCT00625833</DOCNO>
	<brief_summary>This trial investigate effectiveness safety [ S , S ] -Reboxetine relieve chronic peripheral pain suffer patient diabetes . Some evidence effectiveness [ S , S ] - Reboxetine relieve chronic pain see 3 complete trial .</brief_summary>
	<brief_title>A Trial Of S , S-Reboxetine In Patients With Chronic Painful Diabetic Peripheral Neuropathy .</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Reboxetine</mesh_term>
	<criteria>Male female race least 18 year age Diagnosis painful , distal , symmetrical , sensorymotor polyneuropathy , due diabetes , least 1 year Patients Visit 1 must score â‰¥40 mm Pain Visual Analogue Scale Patients significant hepatic impairment Neurological disorder unrelated diabetic neuropathy may confuse assessment neuropathic pain Any pain condition may confound assessment selfevaluation pain due diabetic neuropathy Amputations toe A current recent diagnosis ( past 6 month ) episode major depressive disorder and/or uncontrolled depression History transient ischemic attack stroke Myocardial infarction unstable angina within past three month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
</DOC>